Monday, November 2nd, 2009
The Centers for Medicare & Medicaid Services (CMS) has determined that its blanket of non-coverage for blood flow measurement using magnetic resonance imaging (MRI) technology contradicts its policies and magnetic resonance angiography (MRA). CMS has eliminated that from the national coverage determination (NCD), effective Sept. 28, and is allowing payers to choose to cover the services. This will impact four codes in January’s outpatient code editor (OCE).
Read more »
Tags: 75558, 75560, 75562, 75564, blood flow, CPT, flow study, morphology, morphology coding, MRA, MRI, MRI coding, national coverage, NCD, OCE, outpatient, outpatient coding, Pub. 100
Comment »
Tuesday, May 12th, 2009
Noridian Administrative Services, LLC (NAS) announced earlier this month that it is retiring certain local coverage determinations (LCDs) and revising a few others.
Read more »
Tags: Cardiology, catheterization, genetic testing, LCD, MAC, MRA, Noridian
1 Comment »
Monday, January 5th, 2009
The U.S. Food and Drug Administration (FDA) has approved Vasovist® (gadofosveset trisodium), a new injectable contrast imaging agent for use in patients undergoing magnetic resonance angiography (MRA).
Read more »
Tags: EPIX, FDA, HCPCS Level II, MRA, MRI, Vasovist
Comment »